世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
神経管理薬の世界市場シェアとランキング、全体売上高と需要予測 2024-2030Drugs of Neuron Management Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 ニューロン管理薬の世界市場は2023年に100万米ドル規模と推定され、2024-2030年の予測期間中にCAGR %で2030年までに100万米ドルの再調整規模になると予測されている。 世界の医薬品市場は2022年に1,475億米ドル... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーニューロン管理薬の世界市場は2023年に100万米ドル規模と推定され、2024-2030年の予測期間中にCAGR %で2030年までに100万米ドルの再調整規模になると予測されている。世界の医薬品市場は2022年に1,475億米ドルで、今後6年間のCAGRは5％で成長する。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億米ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間＆政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要としている患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。 レポートの範囲 本レポートは、神経管理用医薬品の世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総売上高、主要企業の市場シェア、ランキングを中心に包括的に紹介することを目的としています。 神経管理用医薬品の市場規模、推計、予測は、2023年を基準年として、2019年から2030年までの期間の履歴データと予測データを売上高（百万ドル）で提供します。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、ニューロン管理薬に関する情報に基づいたビジネス上の意思決定を行えるよう支援します。 市場区分 企業別 テバ・ファーマシューティカルズ バイオジェン ノバルティスAG ヤンセン・グローバルサービスLLC サノビオン・ファーマシューティカルズ ファイザー サノフィ アラガン アストラゼネカ アコルダ・セラピューティクス タイプ別セグメント 抗けいれん薬 鎮静剤 免疫調節薬 その他 用途別セグメント 病院 特定薬局 その他 地域別 北米 アメリカ カナダ 欧州 ドイツ フランス 英国 イタリア ロシア アジア太平洋 中国 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 各章の概要 第1章： レポートのスコープ、世界の総市場規模を紹介。また本章では、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章 神経管理薬メーカーの競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。 第3章：様々な市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展の可能性を網羅し、読者が様々な市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つ。 第4章：用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場におけるブルーオーシャン市場を見つけるのを助ける。 第5章：地域レベルでのニューロン管理薬の収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、市場規模を紹介しています。 第6章 ニューロン管理薬の国別売上高各国・地域のタイプ別、用途別のシグメイトデータを提供。 第7章：主要企業のプロフィールを提供し、製品収益、売上総利益率、製品紹介、最近の開発など、市場における主要企業の基本状況を詳細に紹介。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 Drugs of Neuron Management Drugs Product Introduction 1.2 Global Drugs of Neuron Management Drugs Market Size Forecast 1.3 Drugs of Neuron Management Drugs Market Trends & Drivers 1.3.1 Drugs of Neuron Management Drugs Industry Trends 1.3.2 Drugs of Neuron Management Drugs Market Drivers & Opportunity 1.3.3 Drugs of Neuron Management Drugs Market Challenges 1.3.4 Drugs of Neuron Management Drugs Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Drugs of Neuron Management Drugs Players Revenue Ranking (2023) 2.2 Global Drugs of Neuron Management Drugs Revenue by Company (2019-2024) 2.3 Key Companies Drugs of Neuron Management Drugs Manufacturing Base Distribution and Headquarters 2.4 Key Companies Drugs of Neuron Management Drugs Product Offered 2.5 Key Companies Time to Begin Mass Production of Drugs of Neuron Management Drugs 2.6 Drugs of Neuron Management Drugs Market Competitive Analysis 2.6.1 Drugs of Neuron Management Drugs Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Drugs of Neuron Management Drugs Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Neuron Management Drugs as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Anticonvulsants 3.1.2 Sedatives 3.1.3 Immunomodulatory 3.1.4 Others 3.2 Global Drugs of Neuron Management Drugs Sales Value by Type 3.2.1 Global Drugs of Neuron Management Drugs Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Drugs of Neuron Management Drugs Sales Value, by Type (2019-2030) 3.2.3 Global Drugs of Neuron Management Drugs Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospital 4.1.2 Specific Pharmacy 4.1.3 Others 4.2 Global Drugs of Neuron Management Drugs Sales Value by Application 4.2.1 Global Drugs of Neuron Management Drugs Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Drugs of Neuron Management Drugs Sales Value, by Application (2019-2030) 4.2.3 Global Drugs of Neuron Management Drugs Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Drugs of Neuron Management Drugs Sales Value by Region 5.1.1 Global Drugs of Neuron Management Drugs Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Drugs of Neuron Management Drugs Sales Value by Region (2019-2024) 5.1.3 Global Drugs of Neuron Management Drugs Sales Value by Region (2025-2030) 5.1.4 Global Drugs of Neuron Management Drugs Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Drugs of Neuron Management Drugs Sales Value, 2019-2030 5.2.2 North America Drugs of Neuron Management Drugs Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Drugs of Neuron Management Drugs Sales Value, 2019-2030 5.3.2 Europe Drugs of Neuron Management Drugs Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Drugs of Neuron Management Drugs Sales Value, 2019-2030 5.4.2 Asia Pacific Drugs of Neuron Management Drugs Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Drugs of Neuron Management Drugs Sales Value, 2019-2030 5.5.2 South America Drugs of Neuron Management Drugs Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Drugs of Neuron Management Drugs Sales Value, 2019-2030 5.6.2 Middle East & Africa Drugs of Neuron Management Drugs Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Drugs of Neuron Management Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Drugs of Neuron Management Drugs Sales Value 6.3 United States 6.3.1 United States Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.3.2 United States Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.4.2 Europe Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.5.2 China Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.5.3 China Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.6.2 Japan Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.7.2 South Korea Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.8.2 Southeast Asia Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.9.2 India Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.9.3 India Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Teva Pharmaceutical lndustries Ltd 7.1.1 Teva Pharmaceutical lndustries Ltd Profile 7.1.2 Teva Pharmaceutical lndustries Ltd Main Business 7.1.3 Teva Pharmaceutical lndustries Ltd Drugs of Neuron Management Drugs Products, Services and Solutions 7.1.4 Teva Pharmaceutical lndustries Ltd Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.1.5 Teva Pharmaceutical lndustries Ltd Recent Developments 7.2 Biogen 7.2.1 Biogen Profile 7.2.2 Biogen Main Business 7.2.3 Biogen Drugs of Neuron Management Drugs Products, Services and Solutions 7.2.4 Biogen Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.2.5 Biogen Recent Developments 7.3 Novartis AG 7.3.1 Novartis AG Profile 7.3.2 Novartis AG Main Business 7.3.3 Novartis AG Drugs of Neuron Management Drugs Products, Services and Solutions 7.3.4 Novartis AG Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.3.5 Janssen GlobalServices, LLC Recent Developments 7.4 Janssen GlobalServices, LLC 7.4.1 Janssen GlobalServices, LLC Profile 7.4.2 Janssen GlobalServices, LLC Main Business 7.4.3 Janssen GlobalServices, LLC Drugs of Neuron Management Drugs Products, Services and Solutions 7.4.4 Janssen GlobalServices, LLC Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.4.5 Janssen GlobalServices, LLC Recent Developments 7.5 Sunovion Pharmaceuticals Inc. 7.5.1 Sunovion Pharmaceuticals Inc. Profile 7.5.2 Sunovion Pharmaceuticals Inc. Main Business 7.5.3 Sunovion Pharmaceuticals Inc. Drugs of Neuron Management Drugs Products, Services and Solutions 7.5.4 Sunovion Pharmaceuticals Inc. Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.5.5 Sunovion Pharmaceuticals Inc. Recent Developments 7.6 Pfizer Inc. 7.6.1 Pfizer Inc. Profile 7.6.2 Pfizer Inc. Main Business 7.6.3 Pfizer Inc. Drugs of Neuron Management Drugs Products, Services and Solutions 7.6.4 Pfizer Inc. Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.6.5 Pfizer Inc. Recent Developments 7.7 Sanofi 7.7.1 Sanofi Profile 7.7.2 Sanofi Main Business 7.7.3 Sanofi Drugs of Neuron Management Drugs Products, Services and Solutions 7.7.4 Sanofi Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.7.5 Sanofi Recent Developments 7.8 Allergan 7.8.1 Allergan Profile 7.8.2 Allergan Main Business 7.8.3 Allergan Drugs of Neuron Management Drugs Products, Services and Solutions 7.8.4 Allergan Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.8.5 Allergan Recent Developments 7.9 AstraZeneca 7.9.1 AstraZeneca Profile 7.9.2 AstraZeneca Main Business 7.9.3 AstraZeneca Drugs of Neuron Management Drugs Products, Services and Solutions 7.9.4 AstraZeneca Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.9.5 AstraZeneca Recent Developments 7.10 Acorda Therapeutics 7.10.1 Acorda Therapeutics Profile 7.10.2 Acorda Therapeutics Main Business 7.10.3 Acorda Therapeutics Drugs of Neuron Management Drugs Products, Services and Solutions 7.10.4 Acorda Therapeutics Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.10.5 Acorda Therapeutics Recent Developments 8 Industry Chain Analysis 8.1 Drugs of Neuron Management Drugs Industrial Chain 8.2 Drugs of Neuron Management Drugs Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Drugs of Neuron Management Drugs Sales Model 8.5.2 Sales Channel 8.5.3 Drugs of Neuron Management Drugs Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Drugs of Neuron Management Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. Table of Contents1 Market Overview1.1 Drugs of Neuron Management Drugs Product Introduction 1.2 Global Drugs of Neuron Management Drugs Market Size Forecast 1.3 Drugs of Neuron Management Drugs Market Trends & Drivers 1.3.1 Drugs of Neuron Management Drugs Industry Trends 1.3.2 Drugs of Neuron Management Drugs Market Drivers & Opportunity 1.3.3 Drugs of Neuron Management Drugs Market Challenges 1.3.4 Drugs of Neuron Management Drugs Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Drugs of Neuron Management Drugs Players Revenue Ranking (2023) 2.2 Global Drugs of Neuron Management Drugs Revenue by Company (2019-2024) 2.3 Key Companies Drugs of Neuron Management Drugs Manufacturing Base Distribution and Headquarters 2.4 Key Companies Drugs of Neuron Management Drugs Product Offered 2.5 Key Companies Time to Begin Mass Production of Drugs of Neuron Management Drugs 2.6 Drugs of Neuron Management Drugs Market Competitive Analysis 2.6.1 Drugs of Neuron Management Drugs Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Drugs of Neuron Management Drugs Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Neuron Management Drugs as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Anticonvulsants 3.1.2 Sedatives 3.1.3 Immunomodulatory 3.1.4 Others 3.2 Global Drugs of Neuron Management Drugs Sales Value by Type 3.2.1 Global Drugs of Neuron Management Drugs Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Drugs of Neuron Management Drugs Sales Value, by Type (2019-2030) 3.2.3 Global Drugs of Neuron Management Drugs Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospital 4.1.2 Specific Pharmacy 4.1.3 Others 4.2 Global Drugs of Neuron Management Drugs Sales Value by Application 4.2.1 Global Drugs of Neuron Management Drugs Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Drugs of Neuron Management Drugs Sales Value, by Application (2019-2030) 4.2.3 Global Drugs of Neuron Management Drugs Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Drugs of Neuron Management Drugs Sales Value by Region 5.1.1 Global Drugs of Neuron Management Drugs Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Drugs of Neuron Management Drugs Sales Value by Region (2019-2024) 5.1.3 Global Drugs of Neuron Management Drugs Sales Value by Region (2025-2030) 5.1.4 Global Drugs of Neuron Management Drugs Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Drugs of Neuron Management Drugs Sales Value, 2019-2030 5.2.2 North America Drugs of Neuron Management Drugs Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Drugs of Neuron Management Drugs Sales Value, 2019-2030 5.3.2 Europe Drugs of Neuron Management Drugs Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Drugs of Neuron Management Drugs Sales Value, 2019-2030 5.4.2 Asia Pacific Drugs of Neuron Management Drugs Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Drugs of Neuron Management Drugs Sales Value, 2019-2030 5.5.2 South America Drugs of Neuron Management Drugs Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Drugs of Neuron Management Drugs Sales Value, 2019-2030 5.6.2 Middle East & Africa Drugs of Neuron Management Drugs Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Drugs of Neuron Management Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Drugs of Neuron Management Drugs Sales Value 6.3 United States 6.3.1 United States Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.3.2 United States Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.4.2 Europe Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.5.2 China Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.5.3 China Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.6.2 Japan Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.7.2 South Korea Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.8.2 Southeast Asia Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Drugs of Neuron Management Drugs Sales Value, 2019-2030 6.9.2 India Drugs of Neuron Management Drugs Sales Value by Type (%), 2023 VS 2030 6.9.3 India Drugs of Neuron Management Drugs Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Teva Pharmaceutical lndustries Ltd 7.1.1 Teva Pharmaceutical lndustries Ltd Profile 7.1.2 Teva Pharmaceutical lndustries Ltd Main Business 7.1.3 Teva Pharmaceutical lndustries Ltd Drugs of Neuron Management Drugs Products, Services and Solutions 7.1.4 Teva Pharmaceutical lndustries Ltd Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.1.5 Teva Pharmaceutical lndustries Ltd Recent Developments 7.2 Biogen 7.2.1 Biogen Profile 7.2.2 Biogen Main Business 7.2.3 Biogen Drugs of Neuron Management Drugs Products, Services and Solutions 7.2.4 Biogen Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.2.5 Biogen Recent Developments 7.3 Novartis AG 7.3.1 Novartis AG Profile 7.3.2 Novartis AG Main Business 7.3.3 Novartis AG Drugs of Neuron Management Drugs Products, Services and Solutions 7.3.4 Novartis AG Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.3.5 Janssen GlobalServices, LLC Recent Developments 7.4 Janssen GlobalServices, LLC 7.4.1 Janssen GlobalServices, LLC Profile 7.4.2 Janssen GlobalServices, LLC Main Business 7.4.3 Janssen GlobalServices, LLC Drugs of Neuron Management Drugs Products, Services and Solutions 7.4.4 Janssen GlobalServices, LLC Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.4.5 Janssen GlobalServices, LLC Recent Developments 7.5 Sunovion Pharmaceuticals Inc. 7.5.1 Sunovion Pharmaceuticals Inc. Profile 7.5.2 Sunovion Pharmaceuticals Inc. Main Business 7.5.3 Sunovion Pharmaceuticals Inc. Drugs of Neuron Management Drugs Products, Services and Solutions 7.5.4 Sunovion Pharmaceuticals Inc. Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.5.5 Sunovion Pharmaceuticals Inc. Recent Developments 7.6 Pfizer Inc. 7.6.1 Pfizer Inc. Profile 7.6.2 Pfizer Inc. Main Business 7.6.3 Pfizer Inc. Drugs of Neuron Management Drugs Products, Services and Solutions 7.6.4 Pfizer Inc. Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.6.5 Pfizer Inc. Recent Developments 7.7 Sanofi 7.7.1 Sanofi Profile 7.7.2 Sanofi Main Business 7.7.3 Sanofi Drugs of Neuron Management Drugs Products, Services and Solutions 7.7.4 Sanofi Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.7.5 Sanofi Recent Developments 7.8 Allergan 7.8.1 Allergan Profile 7.8.2 Allergan Main Business 7.8.3 Allergan Drugs of Neuron Management Drugs Products, Services and Solutions 7.8.4 Allergan Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.8.5 Allergan Recent Developments 7.9 AstraZeneca 7.9.1 AstraZeneca Profile 7.9.2 AstraZeneca Main Business 7.9.3 AstraZeneca Drugs of Neuron Management Drugs Products, Services and Solutions 7.9.4 AstraZeneca Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.9.5 AstraZeneca Recent Developments 7.10 Acorda Therapeutics 7.10.1 Acorda Therapeutics Profile 7.10.2 Acorda Therapeutics Main Business 7.10.3 Acorda Therapeutics Drugs of Neuron Management Drugs Products, Services and Solutions 7.10.4 Acorda Therapeutics Drugs of Neuron Management Drugs Revenue (US$ Million) & (2019-2024) 7.10.5 Acorda Therapeutics Recent Developments 8 Industry Chain Analysis 8.1 Drugs of Neuron Management Drugs Industrial Chain 8.2 Drugs of Neuron Management Drugs Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Drugs of Neuron Management Drugs Sales Model 8.5.2 Sales Channel 8.5.3 Drugs of Neuron Management Drugs Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート本レポートと同じKEY WORD（）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|